Stem Cells
Therapies

Stem Cells Therapies

The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).

FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.

Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.

Check the full list of patients who received stem cell therapy derived from FamiCord labs.

List last update: 06.2026

List of patients who received stem cells from FamiCord Group laboratories

List of patients who received stem cells from FamiCord Group laboratories
Lp.	Source	Source type	Diagnosis	Medical field	Year of application	Therapy	Country	Age of recipient
3101	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2022	Standard Therapy	Poland	54
3102	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2022	Standard Therapy	Poland	63
3103	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2022	Standard Therapy	Poland	54
3104	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2022	Standard Therapy	Poland	71
3105	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2022	Standard Therapy	Poland	67
3106	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia, Type 0 (Cmml-0)	Hematology	2022	Standard Therapy	Poland	64
3107	Apheresis	Allogeneic	Chronic Neutrophilic Leukemia	Hematology	2022	Standard Therapy	Poland	66
3108	Apheresis	Allogeneic	Chronic Neutrophilic Leukemia	Hematology	2022	Standard Therapy	Poland	72
3109	Apheresis	Allogeneic	Combined Immunodeficiency Syndrome With Hyper-Igm	Hematology	2022	Standard Therapy	Poland	6
3110	Apheresis	Allogeneic	Congenital Dyserythropoietic Anemia	Hematology	2022	Standard Therapy	Poland	2
3111	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	68
3112	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	65
3113	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	69
3114	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	50
3115	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	56
3116	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	65
3117	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	47
3118	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma – Relapse	Hematology	2022	Standard Therapy	Germany	66
3119	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic Leukemia	Hematology	2022	Standard Therapy	Germany	66
3120	Apheresis	Autologous	Germ Cell Tumor	Hematology	2022	Standard Therapy	Germany	39
3121	Apheresis	Autologous	Germ Cell Tumor	Hematology	2022	Standard Therapy	Germany	33
3122	Apheresis	Allogeneic	Hemophagocytic Lymphohistiocytosis (Hlh)	Hematology	2022	Standard Therapy	Poland	12
3123	Apheresis	Allogeneic	Hemophagocytic Lymphohistiocytosis (Hlh)	Hematology	2022	Standard Therapy	Poland	21
3124	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2022	Standard Therapy	Poland	26
3125	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2022	Standard Therapy	Poland	31
3126	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2022	Standard Therapy	Poland	53
3127	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2022	Standard Therapy	Poland	25
3128	Apheresis	Autologous	Hodgkin Lymphoma	Hematology	2022	Standard Therapy	Germany	67
3129	Apheresis	Autologous	Hodgkin Lymphoma-Relapse	Hematology	2022	Standard Therapy	Germany	69
3130	Apheresis	Autologous	Hodgkin Lymphoma-Relapse	Hematology	2022	Standard Therapy	Germany	48
3131	Apheresis	Allogeneic	Hypoplastic Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	26
3132	Apheresis	Allogeneic	Immunodeficiency	Hematology	2022	Standard Therapy	Poland	3
3133	Apheresis	Allogeneic	Juvenile Myelomonocytic Leukemia	Hematology	2022	Standard Therapy	Poland	5
3134	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	64
3135	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	61
3136	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	52
3137	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	44
3138	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	53
3139	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	49
3140	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	64
3141	Apheresis	Allogeneic	Mixed Phenotype Acute Leukemia	Hematology	2022	Standard Therapy	Poland	64
3142	Apheresis	Autologous	Morbus Hodgkin	Hematology	2022	Standard Therapy	Germany	36
3143	Apheresis	Autologous	Morbus Hodgkin	Hematology	2022	Standard Therapy	Germany	62
3144	Apheresis	Autologous	Morbus Hodgkin-Relapse	Hematology	2022	Standard Therapy	Germany	63
3145	Apheresis	Allogeneic	Mucopolysaccharidosis	Hematology	2022	Standard Therapy	Poland	2
3146	Apheresis	Allogeneic	Mucopolysaccharidosis Type I	Hematology	2022	Standard Therapy	Poland	3
3147	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	58
3148	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	53
3149	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	57
3150	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	64
3151	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	50
3152	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	67
3153	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	55
3154	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	73
3155	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	63
3156	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	65
3157	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	58
3158	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	37
3159	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	47
3160	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	68
3161	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	53
3162	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	60
3163	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	60
3164	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	47
3165	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	59
3166	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	64
3167	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	59
3168	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	52
3169	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	73
3170	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	68
3171	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	63
3172	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	66
3173	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	50
3174	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	69
3175	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	57
3176	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	55
3177	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	61
3178	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	64
3179	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	71
3180	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	61
3181	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	62
3182	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	60
3183	Apheresis	Autologous	Multiple Myeloma	Hematology	2022	Standard Therapy	Germany	33
3184	Apheresis	Allogeneic	Multiple Myeloma – Relapse	Hematology	2022	Standard Therapy	Germany	43
3185	Apheresis	Autologous	Multiple Myeloma Angioimmunoblastic T-Cell Lymphoma	Hematology	2022	Standard Therapy	Germany	62
3186	Apheresis	Allogeneic	Mycosis Fungoides	Hematology	2022	Standard Therapy	Poland	64
3187	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	65
3188	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	69
3189	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	76
3190	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	45
3191	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	63
3192	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	72
3193	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	70
3194	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	45
3195	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	73
3196	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	21
3197	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	46
3198	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	64
3199	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	71
3200	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2022	Standard Therapy	Poland	49

Page 32 from 89 1 30 31 32 33 34 89